What’s the Problem?
This recall affects:
- Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, white to off-white capsule shaped tablets, debossed with an Andrx logo with “571”on one side and “500” on the opposite side.
- Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, light yellow capsule shaped tablets, debossed with an Andrx logo with “577” on one side and “750” on the opposite side.
Teva Pharmaceuticals USA, Inc., issued the recall after FDA testing found “NDMA levels in excess of the Acceptable Daily Intake Limit (ADI).” Exposure to NDMA has been linked to the following serious side effects:
- Prostate cancer
- Lower esophageal cancer
- Non-hodgkin lymphoma
- Multiple myeloma
- Colon cancer
- Stomach cancer
- Intestinal cancer
- Pancreatic cancer
- Liver failure
- And more
Consumers who were prescribed metformin that is affected by this recall should consult their physician about alternative treatment options. This recall began on 6/2/20.
Do I Have an Actavis Metformin Recall Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Actavis Metformin Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new cancer cases in all 50 states.
If you or a loved one has been injured by recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.